Latest News - Another Winning Trade
These shares have BROKEN OUT on very positive
news . This company could become another winning trade for our subscribers.
We feel these shares have turned the corner and formed a solid base at
these levels . BICX offers viable solutions for the opioid epidemic at
hand.
We look for a continued advance setting our next short term
target price at $0.25 almost a double from current levels.
Strong Buy
BioCorRx Submits Pre-IND Package to FDA for its Naltrexone Implant, BICX102
BioCorRx Announces Nine Centers to Implement BioCorRx Recovery Program Across Maryland and Virginia